Identification and characterization of HIV-2 strains obtained from asymptomatic patients that do not use CCR5 or CXCR4 coreceptors

Virology

Volumn 313, Issue 1, 2003, Pages 136-146

  Azevedo Pereira, J M ^a   Santos Costa, Q ^a   Mansinho, K ^b   Moniz Pereira, J ^a  

^a UNIVERSITY OF LISBON   (Portugal)

^b HOSPITAL EGAS MONIZ   (Portugal)

Author keywords

Asymptomatic stage; Chemokine receptors; HIV 2; Pathogenesis; Replicative fitness

Indexed keywords

CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; LIGAND; MONOCLONAL ANTIBODY;

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MONONUCLEAR CELL; NONHUMAN; PRIORITY JOURNAL; PROGENY; PROTEIN EXPRESSION; VIRUS ISOLATION; VIRUS REPLICATION; VIRUS STRAIN; VIRUS TRANSMISSION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2;

EID: 0042389472     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0042-6822(03)00343-X     Document Type: Article

References (91)

1. Aarons E.J., Beddows S., Willingham T., Wu L., Koup R.A. Adaptation to blockade of human immunodeficiency virus type 1 entry imposed by the anti-CCR5 monoclonal antibody 2D7. Virology. 287:2001;382-390.
2. Adjorlolo-Johnson G., De Cock K.M., Ekpini E., Vetter K.M., Sibailly T., Brattegaard K., Yavo D., Doorly R., Whitaker J.P., Kestens L. Prospective comparison of mother-to-child transmission of HIV-1 and HIV-2 in Abidjan, Ivory Coast. JAMA. 272:1994;462-466.
3. Alkhatib G., Combadiere C., Broder C.C., Feng Y., Kennedy P.E., Murphy P.M., Berger E.A. CC CKR5 a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1 . Science. 272:1996;1955-1958.
4. Andreasson P.A., Dias F., Naucler A., Andersson S., Biberfeld G. A prospective study of vertical transmission of HIV-2 in Bissau, Guinea-Bissau. AIDS. 7:1993;989-993.
5. Arthos J., Rubbert A., Rabin R.L., Cicala C., Machado E., Wildt K., Hanbach M., Steenbeke T.D., Swofford R., Farber J.M., Fauci A.S. CCR5 signal transduction in macrophages by human immunodeficiency virus and simian immunodeficiency virus envelopes. J. Virol. 74:2000;6418-6424.
6. Ashorn P.A., Berger E.A., Moss B. Human immunodeficiency virus envelope glycoprotein/CD4-mediated fusion of nonprimate cells with human cells. J. Virol. 64:1990;2149-2156.
7. Baik S.S., Doms R.W., Doranz B.J. HIV and SIV gp120 binding does not predict coreceptor function. Virology. 259:1999;267-273.
8. Balotta C., Bagnarelli P., Violin M., Ridolfo A.L., Zhou D., Berlusconi A., Corvasce S., Corbellino M., Clementi M., Clerici M., Moroni M., Galli M. Homozygous delta 32 deletion of the CCR-5 chemokine receptor gene in an HIV-1-infected patient. AIDS. 11:1997;F67-F71.
9. Berger E.A., Doms R.W., Fenyo E.M., Korber B.T., Littman D.R., Moore J.P., Sattentau Q.J., Schuitemaker H., Sodroski J., Weiss R.A. A new classification for HIV-1. Nature. 391:1998;240.
10. Berger E.A., Murphy P.M., Farber J.M. Chemokine receptors as HIV-1 coreceptors roles in viral entry, tropism, and disease . Annu. Rev. Immunol. 17:1999;657-700.
11. Biti R., Ffrench R., Young J., Bennetts B., Stewart G., Liang T. HIV-1 infection in an individual homozygous for the CCR5 deletion allele. Nat. Med. 3:1997;252-253.
12. Bjorndal A., Deng H., Jansson M., Fiore J.R., Colognesi C., Karlsson A., Albert J., Scarlatti G., Littman D.R., Fenyo E.M. Coreceptor usage of primary human immunodeficiency virus type 1 isolates varies according to biological phenotype. J. Virol. 71:1997;7478-7487.
13. Bleul C.C., Farzan M., Choe H., Parolin C., Clark-Lewis I., Sodroski J., Springer T.A. The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature. 382:1996;829-833.
14. Bleul C.C., Wu L., Hoxie J.A., Springer T.A., Mackay C.R. The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes. Proc. Natl. Acad. Sci. USA. 94:1997;1925-1930.
15. Briggs D.R., Tuttle D.L., Sleasman J.W., Goodenow M.M. Envelope V3 amino acid sequence predicts HIV-1 phenotype (co-receptor usage and tropism for macrophages). AIDS. 14:2000;2937-2939.
16. Broder C.C., Jones-Trower A. Human Retroviruses and AIDS a Compilation and Analysis of Nucleic Acid and Amino Acid Sequences . Kuiken C.L., Foley B., Hahn B., Korber B., McCutchan F., Marx P.A., Mellors J.W., Mullins J.I., Sodroski J., Wolinksy S. Theoretical Biology and Biophysics Group. 1999;517-541 Los Alamos National Laboratory, Los Alamos, NM.
17. Bron R., Klasse P.J., Wilkinson D., Clapham P.R., Pelchen-Matthews A., Power C., Wells T.N., Kim J., Peiper S.C., Hoxie J.A., Marsh M. Promiscuous use of CC and CXC chemokine receptors in cell-to-cell fusion mediated by a human immunodeficiency virus type 2 envelope protein. J. Virol. 71:1997;8405-8415.
18. Chackerian B., Long E.M., Luciw P.A., Overbaugh J. Human immunodeficiency virus type 1 coreceptors participate in postentry stages in the virus replication cycle and function in simian immunodeficiency virus infection. J. Virol. 71:1997;3932-3939.
19. Chen Z., Kwon D., Jin Z., Monard S., Telfer P., Jones M.S., Lu C.Y., Aguilar R.F., Ho D.D., Marx P.A. Natural infection of a homozygous delta24 CCR5 red-capped mangabey with an R2b-tropic simian immunodeficiency virus. J. Exp. Med. 188:1998;2057-2065.
20. Chesebro B., Buller R., Portis J., Wehrly K. Failure of human immunodeficiency virus entry and infection in CD4-positive human brain and skin cells. J. Virol. 64:1990;215-221.
21. Clapham P.R., Blanc D., Weiss R.A. Specific cell surface requirements for the infection of CD4-positive cells by human immunodeficiency virus types 1 and 2 and by Simian immunodeficiency virus. Virology. 181:1991;703-715.
22. Clapham P.R., McKnight A. Cell surface receptors, virus entry and tropism of primate lentiviruses. J. Gen. Virol. 83:2002;1809-1829.
23. Clegg A.O., Ashton L.J., Biti R.A., Badhwar P., Williamson P., Kaldor J.M., Stewart G.J. CCR5 promoter polymorphisms, CCR5 59029A and CCR5 59353C, are under represented in HIV-1-infected long-term non-progressors. The Australian Long-Term Non-Progressor Study Group. AIDS. 14:2000;103-108.
24. Cocchi F., DeVico A.L., Garzino-Demo A., Arya S.K., Gallo R.C., Lusso P. Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells. Science. 270:1995;1811-1815.
25. Connor R.I., Ho D.D. Human immunodeficiency virus type 1 variants with increased replicative capacity develop during the asymptomatic stage before disease progression. J. Virol. 68:1994;4400-4408.
26. Connor R.I., Sheridan K.E., Ceradini D., Choe S., Landau N.R. Change in coreceptor use coreceptor use correlates with disease progression in HIV-1-infected individuals. J. Exp. Med. 185:1997;621-628.
27. Dalgleish A.G., Beverley P.C., Clapham P.R., Crawford D.H., Greaves M.F., Weiss R.A. The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature. 312:1984;763-767.
28. De Cock K.M., Adjorlolo G., Ekpini E., Sibailly T., Kouadio J., Maran M., Brattegaard K., Vetter K.M., Doorly R., Gayle H.D. Epidemiology and transmission of HIV-2. Why there is no HIV-2 pandemic. JAMA. 270:1993;2083-2086.
29. Dean M., Carrington M., Winkler C., Huttley G.A., Smith M.W., Allikmets R., Goedert J.J., Buchbinder S.P., Vittinghoff E., Gomperts E., Donfield S., Vlahov D., Kaslow R., Saah A., Rinaldo C., Detels R., O'Brien S.J. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study. Science. 273:1996;1856-1862.
30. Deng H., Liu R., Ellmeier W., Choe S., Unutmaz D., Burkhart M., Di Marzio P., Marmon S., Sutton R.E., Hill C.M., Davis C.B., Peiper S.C., Schall T.J., Littman D.R., Landau N.R. Identification of a major co-receptor for primary isolates of HIV-1. Nature. 381:1996;661-666.
31. Donzella G.A., Schols D., Lin S.W., Este J.A., Nagashima K.A., Maddon P.J., Allaway G.P., Sakmar T.P., Henson G., De Clercq E., Moore J.P. AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor. Nat. Med. 4:1998;72-77.
32. Doranz B.J., Orsini M.J., Turner J.D., Hoffman T.L., Berson J.F., Hoxie J.A., Peiper S.C., Brass L.F., Doms R.W. Identification of CXCR4 domains that support coreceptor and chemokine receptor functions. J. Virol. 73:1999;2752-2761.
33. Dumonceaux J., Nisole S., Chanel C., Quivet L., Amara A., Baleux F., Briand P., Hazan U. Spontaneous mutations in the env gene of the human immunodeficiency virus type 1 NDK isolate are associated with a CD4-independent entry phenotype. J. Virol. 72:1998;512-519.
34. Edinger A.L., Hoffman T.L., Sharron M., Lee B., O'Dowd B., Doms R.W. Use of GPR1, GPR15, and STRL33 as coreceptors by diverse human immunodeficiency virus type 1 and simian immunodeficiency virus envelope proteins. Virology. 249:1998;367-378.
35. Farzan M., Choe H., Martin K., Marcon L., Hofmann W., Karlsson G., Sun Y., Barrett P., Marchand N., Sullivan N., Gerard N., Gerard C., Sodroski J. Two orphan seven-transmembrane segment receptors which are expressed in CD4-positive cells support simian immunodeficiency virus infection. J. Exp. Med. 186:1997;405-411.
36. Feng Y., Broder C.C., Kennedy P.E., Berger E.A. HIV-1 entry cofactor Functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor . Science. 272:1996;872-877.
37. Gartner S., Markovits P., Markovitz D.M., Kaplan M.H., Gallo R.C., Popovic M. The role of mononuclear phagocytes in HTLV-III/LAV infection. Science. 233:1986;215-219.
38. Guillon C., van der Ende M.E., Boers P.H., Gruters R.A., Schutten M., Osterhaus A.D. Coreceptor usage of human immunodeficiency virus type 2 primary isolates and biological clones is broad and does not correlate with their syncytium-inducing capacities. J. Virol. 72:1998;6260-6263.
39. Hu Q., Trent J.O., Tomaras G.D., Wang Z., Murray J.L., Conolly S.M., Navenot J.M., Barry A.P., Greenberg M.L., Peiper S.C. Identification of ENV determinants in V3 that influence the molecular anatomy of CCR5 utilization. J. Mol. Biol. 302:2000;359-375.
40. Jaffar S., Wilkins A., Ngom P.T., Sabally S., Corrah T., Bangali J.E., Rolfe M., Whittle H.C. Rate of decline of percentage CD4+ cells is faster in HIV-1 than in HIV-2 infection. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 16:1997;327-332.
41. Kanki P.J., Travers K.U., Mboup S., Hsieh C.C., Marlink R.G., Gueye-Ndiaye A., Siby T., Thior I., Hernandez-Avila M., Sankale J.L. Slower heterosexual spread of HIV-2 than HIV-1. Lancet. 343:1994;943-946.
42. Klatzmann D., Champagne E., Chamaret S., Gruest J., Guetard D., Hercend T., Gluckman J.C., Montagnier L. T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV. Nature. 312:1984;767-768.
43. Kolchinsky P., Mirzabekov T., Farzan M., Kiprilov E., Cayabyab M., Mooney L.J., Choe H., Sodroski J. Adaptation of a CCR5-using, primary human immunodeficiency virus type 1 isolate for CD4-independent replication. J. Virol. 73:1999;8120-8126.
44. Kostrikis L.G., Neumann A.U., Thomson B., Korber B.T., McHardy P., Karanicolas R., Deutsch L., Huang Y., Lew J.F., McIntosh K., Pollack H., Borkowsky W., Spiegel H.M., Palumbo P., Oleske J., Bardeguez A., Luzuriaga K., Sullivan J., Wolinsky S.M., Koup R.A., Ho D.D., Moore J.P. A polymorphism in the regulatory region of the CC-chemokine receptor 5 gene influences perinatal transmission of human immunodeficiency virus type 1 to African-American infants. J. Virol. 73:1999;10264-10271.
45. Liu Q.H., Williams D.A., McManus C., Baribaud F., Doms R.W., Schols D., De Clercq E., Kotlikoff M.I., Collman R.G., Freedman B.D. HIV-1 gp120 and chemokines activate ion channels in primary macrophages through CCR5 and CXCR4 stimulation. Proc. Natl. Acad. Sci. USA. 97:2000;4832-4837.
46. Liu R., Paxton W.A., Choe S., Ceradini D., Martin S.R., Horuk R., MacDonald M.E., Stuhlmann H., Koup R.A., Landau N.R. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell. 86:1996;367-377.
47. Long E.M., Rainwater S.M., Lavreys L., Mandaliya K., Overbaugh J. HIV type 1 variants transmitted to women in Kenya require the CCR5 coreceptor for entry, regardless of the genetic complexity of the infecting virus. AIDS Res. Hum. Retroviruses. 18:2002;567-576.
48. Maddon P.J., Dalgleish A.G., McDougal J.S., Clapham P.R., Weiss R.A., Axel R. The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain. Cell. 47:1986;333-348.
49. Maréchal V., Clavel F., Heard J.M., Schwartz O. Cytosolic Gag p24 as an index of productive entry of human immunodeficiency virus type 1. J. Virol. 72:1998;2208-2212.
50. Marlink R., Kanki P., Thior I., Travers K., Eisen G., Siby T., Traore I., Hsieh C.C., Dia M.C., Gueye E.H. Reduced rate of disease development after HIV-2 infection as compared to HIV-1. Science. 265:1994;1587-1590.
51. Martinson J.J., Chapman N.H., Rees D.C., Liu Y.T., Clegg J.B. Global distribution of the CCR5 gene 32-basepair deletion. Nat. Genet. 16:1997;100-103.
52. McDermott D.H., Zimmerman P.A., Guignard F., Kleeberger C.A., Leitman S.F., Murphy P.M. CCR5 promoter polymorphism and HIV-1 disease progression. Multicenter AIDS Cohort Study (MACS). Lancet. 352:1998;866-870.
53. McKnight A., Dittmar M.T., Moniz-Periera J., Ariyoshi K., Reeves J.D., Hibbitts S., Whitby D., Aarons E., Proudfoot A.E., Whittle H., Clapham P.R. A broad range of chemokine receptors are used by primary isolates of human immunodeficiency virus type 2 as coreceptors with CD4. J. Virol. 72:1998;4065-4071.
54. McKnight A., Griffiths D.J., Dittmar M., Clapham P., Thomas E. Characterization of a late entry event in the replication cycle of human immunodeficiency virus type 2. J. Virol. 75:2001;6914-6922.
55. McKnight A., Wilkinson D., Simmons G., Talbot S., Picard L., Ahuja M., Marsh M., Hoxie J.A., Clapham P.R. Inhibition of human immunodeficiency virus fusion by a monoclonal antibody to a coreceptor (CXCR4) is both cell type and virus strain dependent. J. Virol. 71:1997;1692-1696.
56. Michael N.L., Louie L.G., Sheppard H.W. CCR5-delta 32 gene deletion in HIV-1 infected patients. Lancet. 350:1997;741-742.
57. Michael N.L., Nelson J.A., KewalRamani V.N., Chang G., O'Brien S.J., Mascola J.R., Volsky B., Louder M., White G.C., Littman D.R., Swanstrom R., O'Brien T.R. Exclusive and persistent use of the entry coreceptor CXCR4 by human immunodeficiency virus type 1 from a subject homozygous for CCR5 delta32. J. Virol. 72:1998;6040-6047.
58. Morner A., Bjorndal A., Albert J., KewalRamani V.N., Littman D.R., Inoue R., Thorstensson R., Fenyo E.M., Bjorling E. Primary human immunodeficiency virus type 2 (HIV-2) isolates, like HIV-1 isolates, frequently use CCR5 but show promiscuity in coreceptor usage. J. Virol. 73:1999;2343-2349.
59. Mummidi S., Ahuja S.S., Gonzalez E., Anderson S.A., Santiago E.N., Stephan K.T., Craig F.E., O'Connell P., Tryon V., Clark R.A., Dolan M.J., Ahuja S.K. Genealogy of the CCR5 locus and chemokine system gene variants associated with altered rates of HIV-1 disease progression. Nat. Med. 4:1998;786-793.
60. O'Brien T.R., Winkler C., Dean M., Nelson J.A., Carrington M., Michael N.L., White G.C. HIV-1 infection in a man homozygous for CCR5 delta 32. Lancet. 349:1997;1219.
61. Oberlin E., Amara A., Bachelerie F., Bessia C., Virelizier J.L., Arenzana-Seisdedos F., Schwartz O., Heard J.M., Clark-Lewis I., Legler D.F., Loetscher M., Baggiolini M., Moser B. The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1. Nature. 382:1996;833-835.
62. Olson W.C., Rabut G., Nagashima K.A., Tran D.N., Anselma D.J., Monard S.P., Segal J.P., Thompson D.A., Kajumo F., Guo Y., Moore J.P., Maddon P.J., Dragic T. Differential inhibition of human immunodeficiency virus type 1 fusion, gp120 binding, and CC-chemokine activity by monoclonal antibodies to CCR5. J. Virol. 73:1999;4145-4155.
63. Ostrowski M.A., Krakauer D.C., Li Y., Justement S.J., Learn G., Ehler L.A., Stanley S.K., Nowak M., Fauci A.S. Effect of immune activation on the dynamics of human immunodeficiency virus replication and on the distribution of viral quasispecies. J. Virol. 72:1998;7772-7784.
64. Owen S.M., Ellenberger D., Rayfield M., Wiktor S., Michel P., Grieco M.H., Gao F., Hahn B.H., Lal R.B. Genetically divergent strains of human immunodeficiency virus type 2 use multiple coreceptors for viral entry. J. Virol. 72:1998;5425-5432.
65. Poulsen A.G., Aaby P., Larsen O., Jensen H., Naucler A., Lisse I.M., Christiansen C.B., Dias F., Melbye M. 9-year HIV-2-associated mortality in an urban community in Bissau, west Africa. Lancet. 349:1997;911-914.
66. Reeves J.D., Doms R.W. Human immunodeficiency virus type 2. J. Gen. Virol. 83:2002;1253-1265.
67. Reeves J.D., Schulz T.F. The CD4-independent tropism of human immunodeficiency virus type 2 involves several regions of the envelope protein and correlates with a reduced activation threshold for envelope-mediated fusion. J. Virol. 71:1997;1453-1465.
68. Reeves J.D., Hibbitts S., Simmons G., McKnight A., Azevedo-Pereira J.M., Moniz-Pereira J., Clapham P.R. Primary human immunodeficiency virus type 2 (HIV-2) isolates infect CD4-negative cells via CCR5 and CXCR4 comparison with HIV-1 and simian immunodeficiency virus and relevance to cell tropism in vivo . J. Virol. 73:1999;7795-7804.
69. Richman D.D., Bozzette S.A. The impact of the syncytium-inducing phenotype of human immunodeficiency virus on disease progression. J. Infect. Dis. 169:1994;968-974.
70. Roederer M., Raju P.A., Mitra D.K., Herzenberg L.A. HIV does not replicate in naive CD4 T cells stimulated with CD3/CD28. J. Clin. Invest. 99:1997;1555-1564.
71. Saha K., Zhang J., Gupta A., Dave R., Yimen M., Zerhouni B. Isolation of primary HIV-1 that target CD8+ T lymphocytes using CD8 as a receptor. Nat. Med. 7:2001;65-72.
72. Salvatori F., Scarlatti G. HIV type 1 chemokine receptor usage in mother-to-child transmission. AIDS Res. Hum. Retroviruses. 17:2001;925-935.
73. Samson M., Edinger A.L., Stordeur P., Rucker J., Verhasselt V., Sharron M., Govaerts C., Mollereau C., Vassart G., Doms R.W., Parmentier M. ChemR23, a putative chemoattractant receptor, is expressed in monocyte-derived dendritic cells and macrophages and is a coreceptor for SIV and some primary HIV-1 strains. Eur. J. Immunol. 28:1998;1689-1700.
74. Samson M., Libert F., Doranz B.J., Rucker J., Liesnard C., Farber C.M., Saragosti S., Lapoumeroulie C., Cognaux J., Forceille C., Muyldermans G., Verhofstede C., Burtonboy G., Georges M., Imai T., Rana S., Yi Y., Smyth R.J., Collman R.G., Doms R.W., Vassart G., Parmentier M. Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature. 382:1996;722-725.
75. Scarlatti G., Tresoldi E., Bjorndal A., Fredriksson R., Colognesi C., Deng H.K., Malnati M.S., Plebani A., Siccardi A.G., Littman D.R., Fenyo E., Lusso P. In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression. Nat. Med. 3:1997;1259-1265.
76. Schols D., De Clercq E. The simian immunodeficiency virus mnd(GB-1) strain uses CXCR4, not CCR5, as coreceptor for entry in human cells. J. Gen. Virol. 79:1998;2203-2205.
77. Shimizu N., Haraguchi Y., Takeuchi Y., Soda Y., Kanbe K., Hoshino H. Changes in and discrepancies between cell tropisms and coreceptor uses of human immunodeficiency virus type 1 induced by single point mutations at the V3 tip of the env protein. Virology. 259:1999;324-333.
78. Shimizu N., Soda Y., Kanbe K., Liu H.Y., Mukai R., Kitamura T., Hoshino H. A putative G protein-coupled receptor, RDC1, is a novel coreceptor for human and simian immunodeficiency viruses. J. Virol. 74:2000;619-626.
79. Simmons G., Reeves J.D., Hibbitts S., Stine J.T., Gray P.W., Proudfoot A.E., Clapham P.R. Co-receptor use by HIV and inhibition of HIV infection by chemokine receptor ligands. Immunol. Rev. 177:2000;112-126.
80. Simmons G., Wilkinson D., Reeves J.D., Dittmar M.T., Beddows S., Weber J., Carnegie G., Desselberger U., Gray P.W., Weiss R.A., Clapham P.R. Primary, syncytium-inducing human immunodeficiency virus type 1 isolates are dual-tropic and most can use either Lestr or CCR5 as coreceptors for virus entry. J. Virol. 70:1996;8355-8360.
81. Sol N., Ferchal F., Braun J., Pleskoff O., Treboute C., Ansart I., Alizon M. Usage of the coreceptors CCR-5, CCR-3, and CXCR-4 by primary and cell line-adapted human immunodeficiency virus type 2. J. Virol. 71:1997;8237-8244.
82. Spina C.A., Prince H.E., Richman D.D. Preferential replication of HIV-1 in the CD45RO memory cell subset of primary CD4 lymphocytes in vitro. J. Clin. Invest. 99:1997;1774-1785.
83. Stevenson M., Stanwick T.L., Dempsey M.P., Lamonica C.A. HIV-1 replication is controlled at the level of T cell activation and proviral integration. EMBO J. 9:1990;1551-1560.
84. Verrier F., Borman A.M., Brand D., Girard M. Role of the HIV type 1 glycoprotein 120 V3 loop in determining coreceptor usage. AIDS Res. Hum. Retroviruses. 15:1999;731-743.
85. Weissman D., Rabin R.L., Arthos J., Rubbert A., Dybul M., Swofford R., Venkatesan S., Farber J.M., Fauci A.S. Macrophage-tropic HIV and SIV envelope proteins induce a signal through the CCR5 chemokine receptor. Nature. 389:1997;981-985.
86. Whittle H., Morris J., Todd J., Corrah T., Sabally S., Bangali J., Ngom P.T., Rolfe M., Wilkins A. HIV-2-infected patients survive longer than HIV-1-infected patients. AIDS. 8:1994;1617-1620.
87. Woods T.C., Roberts B.D., Butera S.T., Folks T.M. Loss of inducible virus in CD45RA naive cells after human immunodeficiency virus-1 entry accounts for preferential viral replication in CD45RO memory cells. Blood. 89:1997;1635-1641.
88. Wu L., LaRosa G., Kassam N., Gordon C.J., Heath H., Ruffing N., Chen H., Humblias J., Samson M., Parmentier M., Moore J.P., Mackay C.R. Interaction of chemokine receptor CCR5 with its ligands multiple domains for HIV-1 gp120 binding and a single domain for chemokine binding . J. Exp. Med. 186:1997;1373-1381.
89. Yi Y., Singh A., Isaacs S.N., Collman R.G. A CCR5/CXCR4-independent coreceptor pathway on human macrophages supports efficient SIV env-mediated fusion but not infection implications for alternative pathways of viral entry . Virology. 284:2001;142-151.
90. Zhang L., He T., Huang Y., Chen Z., Guo Y., Wu S., Kunstman K.J., Brown R.C., Phair J.P., Neumann A.U., Ho D.D., Wolinsky S.M. Chemokine coreceptor usage by diverse primary isolates of human immunodeficiency virus type 1. J. Virol. 72:1998;9307-9312.
91. Zhang Y., Lou B., Lal R.B., Gettie A., Marx P.A., Moore J.P. Use of inhibitors to evaluate coreceptor usage by simian and simian/human immunodeficiency viruses and human immunodeficiency virus type 2 in primary cells. J. Virol. 74:2000;6893-6910.